Characterization of the cytotoxic effects of the combination of cisplatin and flavanol (-)-epicatechin on human lung cancer cell line A549. An isobolographic approach
Background: Among malignancies, lung cancer is a leading cause of death. Platinum-based therapeutic compounds used to treat lung cancer have not been able to increase the survival of patients and such compounds have a high incidence of adverse and toxic effects. It has been proposed that flavonoids...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2018 |
| Main Authors: | Varela-Castillo, O., Cordero, P., Gutiérrez-Iglesias, G., Palma, I., Rubio-Gayosso, I., Meaney, E., Ramirez-Sanchez, I., Villarreal, F., Ceballos, G., Nájera, N. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2018
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/139247 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Characterization of the cytotoxic effects of the combination of cisplatin and flavanol (-)-epicatechin on human lung cancer cell line A549. An isobolographic approach / O. Varela-Castillo, P. Cordero, G. Gutiérrez-Iglesias, I. Palma, I. Rubio-Gayosso, E. Meaney, I. Ramirez-Sanchez, F. Villarreal, G. Ceballos, N. Nájera // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 19-23. — Бібліогр.: 25 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Synergistic effects of taurine and cisplatin on lung cancer cells (A549)
by: F. J. Jouni, et al.
Published: (2023)
by: F. J. Jouni, et al.
Published: (2023)
In vitro modification of cisplatin cytotoxicity with magnetic fluid
by: Chekhun, V.F., et al.
Published: (2013)
by: Chekhun, V.F., et al.
Published: (2013)
Antineoplastic therapy by radioactive cisplatin in experiment
by: Dikiy, N.P., et al.
Published: (2007)
by: Dikiy, N.P., et al.
Published: (2007)
Enhanced cytotoxicity of rhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells
by: D. V. Franskevych, et al.
Published: (2015)
by: D. V. Franskevych, et al.
Published: (2015)
Ferrofluids based cisplatin for application in cancer therapy
by: N. V. Abramov
Published: (2013)
by: N. V. Abramov
Published: (2013)
Activation of store – operated Ca2+ entry in cisplatin resistant leukemic cells after treatment with photoexcited fullerene C60 and cisplatin
by: D. V. Franskevych, et al.
Published: (2018)
by: D. V. Franskevych, et al.
Published: (2018)
Aggregation processes in hybrid nanosystem polymer/nanosilver/cisplatin
by: N. Kutsevol, et al.
Published: (2018)
by: N. Kutsevol, et al.
Published: (2018)
Aggregation processes in hybrid nanosystem polymer/nanosilver/cisplatin
by: N. Kutsevol, et al.
Published: (2018)
by: N. Kutsevol, et al.
Published: (2018)
Enterosorption as a method to decrease the systemic toxicity of cisplatin
by: Sakhno, L.A., et al.
Published: (2013)
by: Sakhno, L.A., et al.
Published: (2013)
Effect of glucose starvation on cell viability parameters in A549 and BEAS-2B cell lines
by: B. G. Зetiner, et al.
Published: (2022)
by: B. G. Зetiner, et al.
Published: (2022)
Plasminogen/plasmin affects expression of glycolysis regulator TIGAR and induces autophagy in lung adenocarcinoma A549 cells
by: Tykhomyrov, A.A., et al.
Published: (2023)
by: Tykhomyrov, A.A., et al.
Published: (2023)
Prx II and CKBB proteins interaction under physiological and thermal stress conditions in A549 and HeLa cells
by: A. D. Rakhmetov, et al.
Published: (2016)
by: A. D. Rakhmetov, et al.
Published: (2016)
Morphological changes in rat liver and kidneys after HIPEC modeling with cisplatine
by: O. D. Pykhtieieva, et al.
Published: (2019)
by: O. D. Pykhtieieva, et al.
Published: (2019)
Estimation of the absorbed doses of synthesized cisplatin with ¹⁹⁵mPt in various organs of animals
by: Dikiy, N.P., et al.
Published: (2008)
by: Dikiy, N.P., et al.
Published: (2008)
Prevention of cisplatin toxicity against normal cells by complexation with C60 fullerene
by: S. V. Prylutska, et al.
Published: (2020)
by: S. V. Prylutska, et al.
Published: (2020)
Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
by: Burlaka, A.P., et al.
Published: (2015)
by: Burlaka, A.P., et al.
Published: (2015)
Effects of C 60 fullerene — cisplatin complex on honeybee Apis mellifera L.
by: H. M. Kuznietsova, et al.
Published: (2015)
by: H. M. Kuznietsova, et al.
Published: (2015)
Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
by: A. P. Burlaka, et al.
Published: (2015)
by: A. P. Burlaka, et al.
Published: (2015)
Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009)
by: Lukyanova, N.Yu., et al.
Published: (2009)
Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro
by: Yerushalmi, R., et al.
Published: (2007)
by: Yerushalmi, R., et al.
Published: (2007)
Adaptor protein RuK/CIN85 Induces epithelial-to-mesenchymal tr ansition in human A549 lung adenocarcinoma cells
by: O. S. Vasheniuk, et al.
Published: (2018)
by: O. S. Vasheniuk, et al.
Published: (2018)
Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
by: Potebnya, G.P., et al.
Published: (2009)
by: Potebnya, G.P., et al.
Published: (2009)
Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: Chekhun, V.F., et al.
Published: (2014)
by: Chekhun, V.F., et al.
Published: (2014)
Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: V. F. Chekhun, et al.
Published: (2014)
by: V. F. Chekhun, et al.
Published: (2014)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
by: I. G. Tkalia, et al.
Published: (2015)
by: I. G. Tkalia, et al.
Published: (2015)
On the proposed martensitic-like structural transformation in V, Nb, and Ta
by: Cordero, F.
Published: (2018)
by: Cordero, F.
Published: (2018)
On the proposed martensitic-like structural transformation in V, Nb, and Ta
by: F. Cordero
Published: (2018)
by: F. Cordero
Published: (2018)
Adsorption of cisplatin by the surface of the magnetic sensitive nanocomposite Fe3O4/Al2O3/S
by: P. P. Gorbyk, et al.
Published: (2021)
by: P. P. Gorbyk, et al.
Published: (2021)
Modulation of cisplatin-induced reactive oxygen species production by fullerene C60 in normal and transformed lymphoid cells
by: D. V. Franskevych, et al.
Published: (2016)
by: D. V. Franskevych, et al.
Published: (2016)
ВПЛИВ МОНОКЛОНАЛЬНИХ АНТИТІЛ ДО TSLPR НА ЖИТТЄЗДАТНІСТЬ КЛІТИН MCF-7 ТА A549, ЕКСПРЕСІЮ В НИХ ПРОАПОПТОТИЧНИХ ГЕНІВ ТА ПРОДУКЦІЮ ПРОЗАПАЛЬНИХ ЦИТОКІНІВ
by: Rakha, Alyaa, et al.
Published: (2023)
by: Rakha, Alyaa, et al.
Published: (2023)
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
by: I. G. Tkalia, et al.
Published: (2014)
by: I. G. Tkalia, et al.
Published: (2014)
Alteration in lipid composition of plasma membranes of sensitive and resistant Guerin carcinoma cells due to the action of free and liposomal form of cisplatin
by: L. A. Naleskina, et al.
Published: (2013)
by: L. A. Naleskina, et al.
Published: (2013)
НЕЙРОЕНДОКРИННІ ПЕПТИДИ В ПАТОГЕНЕЗІ КОЛОРЕКТАЛЬНОГО РАКУ
by: Ramírez-Perdomo, A., et al.
Published: (2023)
by: Ramírez-Perdomo, A., et al.
Published: (2023)
Overexpression/knockdown of adaptor protein RUK/CIN85 in human lung adenocarcinoma A549 cells results in opposite changes between MMP-2/MMP-9 xpression levels/activities and cell`s invasion
by: M. I. Bekala, et al.
Published: (2023)
by: M. I. Bekala, et al.
Published: (2023)
Cisplatin treatment of C6 rat glioma in vivo did not influence copy number alterations and growth pattern of tumor-derived resistant cells
by: A. A. Stepanenko, et al.
Published: (2015)
by: A. A. Stepanenko, et al.
Published: (2015)
Cisplatin treatment of C6 rat glioma in vivo did not influence copy number alterations and growth pattern of tumor-derived resistant cells
by: Stepanenko, A.A., et al.
Published: (2015)
by: Stepanenko, A.A., et al.
Published: (2015)
Meron-cluster simulation of the quantum antiferromagnetic Heisenberg model in a magnetic field in one- and two-dimensions
by: Palma, G., et al.
Published: (2015)
by: Palma, G., et al.
Published: (2015)
Determination of cisplatin in human blood plasma and urine using liquid chromatography-mass spectrometry for oncological patients with a variety of fatty tissue mass for prediction of toxicity
by: Gerina-Berzina, A., et al.
Published: (2017)
by: Gerina-Berzina, A., et al.
Published: (2017)
Elliptic and -Analogs of the Fibonomial Numbers
by: Bergeron, Nantel, et al.
Published: (2020)
by: Bergeron, Nantel, et al.
Published: (2020)
Similar Items
-
Synergistic effects of taurine and cisplatin on lung cancer cells (A549)
by: F. J. Jouni, et al.
Published: (2023) -
In vitro modification of cisplatin cytotoxicity with magnetic fluid
by: Chekhun, V.F., et al.
Published: (2013) -
Antineoplastic therapy by radioactive cisplatin in experiment
by: Dikiy, N.P., et al.
Published: (2007) -
Enhanced cytotoxicity of rhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells
by: D. V. Franskevych, et al.
Published: (2015) -
Ferrofluids based cisplatin for application in cancer therapy
by: N. V. Abramov
Published: (2013)